Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125555351 | 12555535 | 1 | I | 20130216 | 0 | 20160713 | 20160713 | DIR | 8.71 | YR | F | N | 18.10000 | KG | 20160627 | N | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125555351 | 12555535 | 1 | PS | DACTINOMYCIN | DACTINOMYCIN | 1 | D | D | 0 | 2.53 | MG | ||||||||
| 125555351 | 12555535 | 2 | SS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | 0 | 46 | MG | ||||||||||
| 125555351 | 12555535 | 3 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | 0 | 7.5 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125555351 | 12555535 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125555351 | 12555535 | Disease recurrence | |
| 125555351 | 12555535 | Multiple organ dysfunction syndrome | |
| 125555351 | 12555535 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 125555351 | 12555535 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125555351 | 12555535 | 1 | 20100415 | 0 | ||
| 125555351 | 12555535 | 2 | 20100325 | 0 | ||
| 125555351 | 12555535 | 3 | 20100415 | 0 |